Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000005751 | SCV004642207 | pathogenic | Hemochromatosis type 4 | 2024-02-14 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 267 of the SLC40A1 protein (p.Gly267Asp). This variant is present in population databases (rs104893664, gnomAD 0.05%). This missense change has been observed in individual(s) with isolated hyperferritinemia (PMID: 16351644). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 5418). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The aspartic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000005751 | SCV000025933 | pathogenic | Hemochromatosis type 4 | 2005-12-01 | no assertion criteria provided | literature only | |
Laboratory of Molecular Genetics and Genomics, |
RCV000005751 | SCV001445855 | likely pathogenic | Hemochromatosis type 4 | 2020-07-01 | no assertion criteria provided | clinical testing |